RBP-8000 100 mg
RB-US-13-0004
Phase 2 small_molecule completed
Quick answer
RBP-8000 100 mg for Opioid Dependence is a Phase 2 program (small_molecule) at Indivior Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Indivior Pharmaceuticals
- Indication
- Opioid Dependence
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed